Patent · US Expired

1-Alka-2,4-dienyl-2-hydroxymethyl-3,4,5-trihydroxypiperidines as inhibitors of .alpha.-glucoside hydrolases

US4312872A · kind A · utility

6Cited by

1References

10Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Bodo Junge · Wuppertal, DE
Lutz Muller · Elkhart, US
Rudiger Sitt · Wuppertal, DE
Gunter Thomas · Arese, IT
Hans-Peter Krause · Hofheim, DE
Walter Puls · Wuppertal, DE

Key dates

Filing date	Jun 11, 1980
Grant date	Jan 26, 1982
Priority date	—
Expiry date	Jun 11, 2000

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 1-alka-2,4-dienyl-2-hydroxymethyl-3,4,5-trihydroxypiperidine compounds which are, inter alia, potent inhibitors for .alpha.- glucoside hydrolases and effect lipid absorption. Also included in the invention are methods for the manufacture of the said compounds, compositions containing said compounds and methods for the use of said compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.